HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

IMPROVE-IT and genetics reaffirm the causal role of LDL in Cardiovascular Disease.

AuthorsAlberico L Catapano, Brian A Ference
JournalAtherosclerosis (Atherosclerosis) Vol. 241 Issue 2 Pg. 498-501 (Aug 2015) ISSN: 1879-1484 [Electronic] Ireland
PMID26091974 (Publication Type: Journal Article)
Chemical References
  • Cholesterol, LDL
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Membrane Proteins
  • Membrane Transport Proteins
  • NPC1L1 protein, human
  • Ezetimibe
Topics
  • Cardiovascular Diseases (blood, etiology, genetics)
  • Cholesterol, LDL (blood)
  • Drug Approval
  • Ezetimibe (administration & dosage)
  • Genetic Predisposition to Disease
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors (administration & dosage)
  • Membrane Proteins (genetics)
  • Membrane Transport Proteins
  • Mendelian Randomization Analysis
  • Randomized Controlled Trials as Topic
  • Research Design

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: